Interestingly, lncRNA MALAT1 and NEAT1 have been found to serve as novel immunoregulators affecting monocyte‐macrophage functions and their disruption may contribute to identifying high risk in post‐MI and atherosclerosis patients.93, 94. The gene discussed is MALAT1; the disease is atherosclerosis.